おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Shape Therapeutics
company
About
A biotechnology company developing RNA technologies to shape the future of gene therapy
- 51 - 100
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $35.50M
- Industries
- Biotechnology
- Founded date
- Apr 5, 2018
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Shape Therapeutics (ShapeTX) is a biotechnology company with an end-to-end approach to RNA Gene Therapy, potentially enabling the development of cures in neurodegenerative, metabolic and rare genetic diseases through our breakthrough payload, delivery, and manufacturing platform technologies. Our vision is to facilitate adoption of these technologies throughout the industry to develop effective treatments for as many patients as possible.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$35.50M
Shape Therapeutics has raised a total of
$35.50M
in funding over 2 rounds. Their latest funding was raised on
Nov 6, 2019 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 6, 2019 | Series A | $35.50M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Shape Therapeutics is funded by 1 investors.
CureDuchenne Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
CureDuchenne Ventures
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
